Calciphylaxis Companies
Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare and serious medical condition characterized by the calcification of small and medium-sized blood vessels, leading to tissue ischemia and necrosis. This condition often occurs in patients with chronic kidney disease, particularly those undergoing dialysis. Companies involved in the field of calciphylaxis may be focused on research, development, and commercialization of diagnostic tools, therapeutic interventions, and supportive care for individuals affected by this condition.